Design, synthesis and α1-adrenoreceptor blocking activity of new arylpiperazines containing acetophenone substituents

Pharmazie

Volumn 69, Issue 8, 2014, Pages 578-584

  Huang, J J ^a   Huang, Y J ^a   Zhu, L ^a   Yuan, Mu ^a   Huang, Li ^a  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACETOPHENONE; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; NAFTOPIDIL; NORADRENALIN; PIPERAZINE DERIVATIVE; TERAZOSIN; ACETOPHENONE DERIVATIVE; ALPHA 1 ADRENERGIC RECEPTOR; DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS; VASODILATOR AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER; CONTROLLED STUDY; DRUG DESIGN; DRUG SYNTHESIS; ENANTIOMER; IN VITRO STUDY; LOWER URINARY TRACT SYMPTOM; NONHUMAN; PROSTATE; PROSTATE HYPERTROPHY; RABBIT; RAT; SMOOTH MUSCLE; THORACIC AORTA; VASCULAR RING; ANIMAL; DRUG EFFECT; MALE; SPLEEN; SPRAGUE DAWLEY RAT; SYNTHESIS; VAS DEFERENS; VASCULAR SMOOTH MUSCLE;

ACETOPHENONES; ADRENERGIC ALPHA-1 RECEPTOR ANTAGONISTS; ANIMALS; AORTA, THORACIC; DRUG DESIGN; INDICATORS AND REAGENTS; MALE; MUSCLE, SMOOTH; MUSCLE, SMOOTH, VASCULAR; PIPERAZINES; PROSTATE; RABBITS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, ALPHA-1; SPLEEN; URINARY BLADDER; VAS DEFERENS; VASODILATOR AGENTS;

EID: 84906729118     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2014.3971     Document Type: Article

References (29)

1. Azuma H, Sugimoto-Tokushima M, Tanaka K, Ikenoue Y, Ito S, Ishikawa M (1989) α1-Adrenoceptor antagonist activity of novel pyrimidine derivatives (SHI437 and IK29) in rabbit aorta and trigone of the bladder. Br J Pharmacol 96: 1000-1006.
2. Azuma H, Ishikawa M, Sekizaki S (1986) Endothelium-dependent inhibition of platelet aggregation. Br J Pharmacol 88: 411-415.
3. Berry SJ, Coffey DS, Walsh PC, Ewing LL (1984) The development of human benign prostatic hyperplasia with age. J Urol 132: 474.
4. Buccioni M, Kandhavelu M, Angeli P, Cristalli G, Dal Ben D, Giardinà D, Lambertucci C, Lammi C, Volpini R, Marucci G (2009) Identification of α1-adrenoceptor subtypes involved in contraction of young CD rat epididymal vas deferens. Eur J Pharmacol 602: 388-394.
5. Buckner SA, Milicic I, Daza AV, Meyer MD, Altenbach RJ, Williams M, Sullivan JP, Brioni JD (2002) ABT-866, a novel α1A-adrenoceptor agonist with antagonist properties at the α1B- and α1D- adrenoceptor subtypes. Eur J Pharmacol 449: 159-165.
6. Cecchetti V, Schiaffella F, Tabarrini O, Fravolini A (2000) (1,4-Benzothiazinyloxy) alkylpiperazine derivatives as potential antihypertensive agents. Bioorg Med Chem Lett 10: 465-468.
7. Delaflotte S, Auguet M, Chabrier P (1996) Pharmacological evidence that different α1 adrenoceptor subtypes mediate contraction in rabbit prostate and hypogastric artery. Acta physiol Scand 158: 241-251.
8. Fagura M, Lydford S, Dougall I (1997) Pharmacological classification of α1-adrenoceptors mediating contractions of rabbit isolated ear artery: comparison with rat isolated thoracic aorta. Br J Pharmacol 120: 247-258.
9. Hancock AA, Buckner SA, Brune ME, Esbenshade TA, Ireland LM, Katwala S, Milicic I, Meyer MD, Kerwin Jr JF, Williams M (2002) Preclinical pharmacology of fiduxosin, a novel α1-adrenoceptor antagonist with uroselective properties. J Pharmacol Exp Ther 300: 478-486.
10. Jain KS, Bariwal JB, Kathiravan MK, Phoujdar MS, Sahne RS, Chauhan BS, Shah AK, Yadav MR (2008) Recent advances in selective α1- adrenoreceptor antagonists as antihypertensive agents. Bioorg Med Chem 16: 4759-4800.
11. Kava MS, Blue DRJr, Vimont RL, Clarke DE, Ford AP (1998) Alpha1L-adrenoceptor mediation of smooth muscle contraction in rabbit bladder neck: a model for lower urinary tract tissues of man. Br J Pharmacol 123: 1359-1366.
12. Klunder JM, Ko SY, Sharpless KB (1986) Asymmetric epoxidation of allyl alcohol: efficient routes to homochiral β-adrenergic blocking agents. J Org Chem 51: 3710-3712.
13. Kojima Y, Sasaki S, Oda N, Koshimizu TA, Hayashi Y, Kiniwa M, Tsujimoto G, Kohri K (2009) Prostate growth inhibition by subtype-selective α1- adrenoceptor antagonist naftopidil in benign prostatic hyperplasia. The Prostate 69: 1521-1528.
14. Marona H, Kubacka M, Filipek B, Siwek A, Dybala M, Szneler E, Pociecha T, Gunia A, Waszkielewicz A (2011) Synthesis,α-adrenoceptors affinity and α1-adrenoceptor antagonistic properties of some 1, 4-substituted piperazine derivatives. Pharmazie 66: 733-739.
15. Marucci G, Angeli P, Buccioni M, Gulini U, Melchiorre C, Sagratini G, Testa R, Giardinà D (2005) (+)-Cyclazosin, a selective α1B-adrenoceptor antagonist: Functional evaluation in rat and rabbit tissues. Eur J Pharmacol 522: 100-107.
16. Michel MC, Vrydag W (2006) α1-, α2- and β-adrenoceptors in the urinary bladder, urethra and prostate. Br J Pharmacol 147: 88-119.
17. Mojid Mondol MA, Kim JH, Lee M, Tareq FS, Lee HS, Lee YJ, Shin HJ (2011) Ieodomycins A-D, Antimicrobial Fatty Acids from a Marine Bacillus sp. J Nat Prod 74: 1606-1612.
18. Nickel JC (2003) The use of α1-adrenoceptor antagonists in lower urinary tract symptoms: beyond benign prostatic hyperplasia. Urology 62: 34-41.
19. Nishino Y, Masue T, Miwa K, Takahashi Y, Ishihara S, Deguchi T (2006) Comparison of two α1-adrenoceptor antagonists, naftopidil and tamsulosin hydrochloride, in the treatment of lower urinary tract symptoms with benign prostatic hyperplasia: a randomized crossover study. BJU Int 97: 747-751.
20. Oger S, Behr-Roussel D, Gorny D, Lebret T, Denoux Y, Alexandre L, Giuliano F (2010) Combination of alfuzosin and tadalafil exerts an additive relaxant effect on human detrusor and prostatic tissues in vitro. Eur Urol 57: 699-707.
21. Palea S, Chang DF, Rekik M, Regnier A, Lluel P (2008) Comparative effect of alfuzosin and tamsulosin on the contractile response of isolated rabbit prostatic and iris dilator smooth muscles: possible model for intraoperative floppy-iris syndrome. J Cataract Refr Surg 34: 489-496.
22. Piao SJ, Zhang HJ, Lu HY, Yang F, Jiao WH, Yi YH, Chen WS, Lin HW (2011) Hippolides A-H, Acyclic Manoalide Derivatives from the Marine Sponge Hippospongia lachne. J Nat Prod 74, 1248-1254.
23. Pollard C, Christie JB (1958) Derivatives of piperazine. XXX. Reactions of 1-arylpiperazines with epoxides. J Org Chem 23: 1333-1335.
24. Rauls DO, Baker JK (1979) Relationship of nonspecific antiarrhythmic and negative inotropic activity with physicochemical parameters of propranolol analogs. J Med Chem 22: 81-86.
25. Schwinn DA, Roehrborn CG (2008) α1-Adrenoceptor subtypes and lower urinary tract symptoms. Int J Urol 15: 193-199.
26. Sorbi C, Franchini S, Tait A, Prandi A, Gallesi R, Angeli P, Marucci G, Pirona L, Poggesi E, Brasili L (2009) 1, 3-Dioxolane-based ligands as rigid analogues of naftopidil: structure-affinity/activity relationships at α1- and 5-HT1A Receptors. ChemMedChem 4: 393-399.
27. Suzuki F, Miyamoto S, Takita M, Oshita M, Watanabe Y, Kakizuka A, Narumiya S, Taniguchi T, Muramatsu I (1997) Cloning, functional expression and tissue distribution of rabbit α1d-adrenoceptor. BBA-Biomembranes 1323: 6-11.
28. Takei R, Ikegaki I, Shibata K, Tsujimoto G, Asano T (1999) Naftopidil, a novel α1-adrenoceptor antagonist, displays selective inhibition of canine prostatic pressure and high affinity binding to cloned human α1-adrenoceptors. Japan J Pharmacol 79: 447-454.
29. Thorpe A, Neal D (2003) Benign prostatic hyperplasia. Lancet 361: 1359-1367.